Bob Rees - EHealth Senior Officer
| EHTH Stock | USD 5.50 0.13 2.42% |
Executive
Bob Rees is Senior Officer of eHealth
| Address | 13620 Ranch Road 620 North, Austin, TX, United States, 78717 |
| Phone | 737 248 2340 |
| Web | https://www.ehealthinsurance.com |
EHealth Management Efficiency
The company has return on total asset (ROA) of (0.0125) % which means that it has lost $0.0125 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0421) %, meaning that it created substantial loss on money invested by shareholders. EHealth's management efficiency ratios could be used to measure how well EHealth manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.03. The current Return On Capital Employed is estimated to decrease to -0.03. As of now, EHealth's Total Current Assets are increasing as compared to previous years. The EHealth's current Intangible Assets is estimated to increase to about 24.8 M, while Other Assets are projected to decrease to under 147.4 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Andrew Bart | Crawford Company | 61 | |
| Bill Matrogran | Erie Indemnity | N/A | |
| Robert IV | Brown Brown | N/A | |
| Robert Mathis | Brown Brown | N/A | |
| Keith Kennedy | Erie Indemnity | N/A | |
| Charles CIC | Erie Indemnity | N/A | |
| Blair Kessler | GoHealth | N/A | |
| Jeffrey CPCU | Erie Indemnity | 55 | |
| Awais Farooq | Crawford Company | N/A | |
| Benedict FCIIA | Crawford Company | 64 | |
| Michael Becker | Crawford Company | N/A | |
| Greg Youngblood | Crawford Company | N/A | |
| CIPM CIPP | Erie Indemnity | N/A | |
| Hong Zhu | Huize Holding | N/A | |
| Sharon OConnor | CorVel Corp | N/A | |
| Michael Vaughan | Brown Brown | N/A | |
| John III | GoHealth | N/A | |
| Larry Thomas | Crawford Company | 64 | |
| Richard Cary | Arthur J Gallagher | 61 | |
| Mark Bloom | Arthur J Gallagher | 60 | |
| Michael Hoberman | Crawford Company | 64 | |
Management Performance
| Return On Equity | -0.0421 | ||||
| Return On Asset | -0.0125 |
eHealth Leadership Team
Elected by the shareholders, the EHealth's board of directors comprises two types of representatives: EHealth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EHealth. The board's role is to monitor EHealth's management team and ensure that shareholders' interests are well served. EHealth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EHealth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kate CFA, Senior Strategy | ||
| Gavin Galimi, General VP | ||
| Eli NewbrunMintz, Senior Manager | ||
| John Dolan, Chief Officer | ||
| Bill Billings, Chief Officer | ||
| Bob Rees, Senior Officer | ||
| Jay Jennings, Senior Finance | ||
| Michelle Barbeau, Senior Officer | ||
| John Stelben, Senior CFO | ||
| Lara Sasken, Senior Communications | ||
| Roman Rariy, COO Officer | ||
| Jana Brown, Senior Officer | ||
| Gregg Ratkovic, Senior Officer | ||
| Ketan Babaria, Senior Officer | ||
| Francis Soistman, CEO Director | ||
| John CPA, Advisor |
EHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EHealth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0421 | ||||
| Return On Asset | -0.0125 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.74) % | ||||
| Current Valuation | 471.26 M | ||||
| Shares Outstanding | 29.63 M | ||||
| Shares Owned By Insiders | 5.30 % | ||||
| Shares Owned By Institutions | 61.13 % | ||||
| Number Of Shares Shorted | 295.63 K | ||||
| Price To Earning | 2.54 X |
Currently Active Assets on Macroaxis
When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.108 | Earnings Share (2.62) | Revenue Per Share 16.016 | Quarterly Revenue Growth (0.1) | Return On Assets (0.01) |
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.